Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Melanoma 65Kidney Neoplasms 24Carcinoma, Renal Cell 23Neoplasm Metastasis 20Breast Neoplasms 16Skin Neoplasms 14Ovarian Neoplasms 11Pancreatic Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Neoplasms 7Uterine Cervical Neoplasms 6Neuroblastoma 6Lymphoma 6Leukemia, Myeloid, Acute 6Leukemia 6Colorectal Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Non-Hodgkin 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Lung Neoplasms 5Colonic Neoplasms 5Urogenital Neoplasms 4Leukemia, Lymphocytic, Chronic, B-Cell 4Carcinoma, Ovarian Epithelial 4Burkitt Lymphoma 4Sezary Syndrome 3Rectal Neoplasms 3Mycosis Fungoides 3

Interventions

Cetuximab 5Radiotherapy 4Docetaxel 3Cisplatin 3Sorafenib 2Sirolimus 2Platinum 2Magnetic Resonance Spectroscopy 2Erlotinib Hydrochloride 21,2-diaminocyclohexaneplatinum II citrate 2temsirolimus 1saracatinib 1ixabepilone 1fluoromisonidazole 1dehydroftorafur 1cediranib 1aldesleukin 1advexin 1adavosertib 1Vorinostat 1Sunitinib 1Soybean Proteins 1Rubidium-82 1Ritonavir 1Radiotherapy, Conformal 1Radiation 1Psychiatric Rehabilitation 1Nicotine 1Neoadjuvant Therapy 1N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Tongue Neoplasms × aldesleukin × Clear all
NCT00002702 2013-08-26

Surgery and Radiation Therapy With or Without Interleukin-2 in Treating Patients With Cancer of the Mouth or Oropharynx

National Cancer Institute (NCI)

Phase 3 Unknown
260 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡